# Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

> **NCT01048814** · — · COMPLETED · sponsor: **Precision Therapeutics** · enrollment: 512 (estimated)

## Conditions studied

- Ovarian Cancer
- Peritoneal Cancer
- Fallopian Tube Cancer

## Interventions

- **OTHER:** ChemoFx

## Key facts

- **NCT ID:** NCT01048814
- **Lead sponsor:** Precision Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 512 (ESTIMATED)
- **Last updated:** 2011-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01048814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01048814, "Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01048814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*